Journals / Journal of Clinical and Analytical Medicine / 2013 / Cilt: 4 - Sayı: 2

Aile hekimlerinin human papillomavirus aşısı hakkındaki bilgi ve tutumları

Family physicians’ knowledge and attitudes about human papillomavirus vaccine

Pages
132–135
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Discussion: In conclusion, because recent studies have shown the preventive effect of the HPV vaccine on precancerous cervical lesions, informing family physicians of the vaccine may lead to an increase of people willing to receive a vaccination.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: In this study, our aim was to evaluate family physicians’ awareness, knowledge and attitudes about the human papillomavirus (HPV) vaccine.
📊
Key Findings & Data:A probability value of p < 0.05 was considered statistically significant.
💡
Conclusion & Impact:Discussion: In conclusion, because recent studies have shown the preventive effect of the HPV vaccine on precancerous cervical lesions, informing family physicians of the vaccine may lead to an increase of people willing to receive a vaccination.
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: In this study, our aim was to evaluate family physicians’ awareness, knowledge and attitudes about the human papillomavirus (HPV) vaccine. Material and Method: Fifty-three family physicians working in different family health care centres were included. A questionnaire including their socio-demographic characteristics, awareness, knowledge and attitudes was administered via the face-to-face conversation method. A probability value of p < 0.05 was considered statistically significant. Results: Only 41 (77.4%) of the family physicians were aware of the HPV vaccine, and 32 (60.4%) had insufficient knowledge about it. Female family physicians’ knowledge was significantly higher than that of their male counterparts (p = 0.028). The predominant source of information about the HPV vaccine in the study group was the media (83.0%). Whereas 26 (49.2%) of the family physicians had no consent for the vaccine because of insufficient knowledge and confidence, the remaining 27 (50.9%) were in favour of it for themselves and their partners and children. Only 33 (62.3%) of the family physicians recommended the vaccine for patients attending the family health centres. Discussion: In conclusion, because recent studies have shown the preventive effect of the HPV vaccine on precancerous cervical lesions, informing family physicians of the vaccine may lead to an increase of people willing to receive a vaccination.

Özet

Amaç: Bu çalışmadaki amacımız, aile hekimlerinin Human papillomavirus (HPV) aşısı hakkındaki farkındalık, bilgi ve tutumlarını değerlendirmekti. Gereç ve Yöntem: Farklı aile sağlığı merkezlerinde çalışan 53 aile hekimi çalışmaya dahil edildi. Sosyo-ekonomik demografik özellikleri, HPV aşısı ile ilgili farkındalık, bilgi ve tutumlarla ilgili soruları içeren bir anket, yüz yüze görüşülerek dolduruldu ve olasılık değeri (p)

🔖

Cite This Article

ARPACI, H., KURTOĞLU, E., TEMÜR, M. (2022). Aile hekimlerinin human papillomavirus aşısı hakkındaki bilgi ve tutumları. Journal of Clinical and Analytical Medicine, Cilt: 4 - Sayı: 2, 132–135. https://ajindex.com/articles/561249

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Cates W. Estimates of the incidence and prevalance of sexually transmitted diseases in the United States. Sez Transm Dis. 1999
  2. 26(suppl):S2 2. Riedesel JM., Rosenthal SL., Zimet GD., Bernstein DI., Huang B., Lan D., Kahn JA. Attitudes about human papillomavirus vaccine among family physicians. J Pediatr Adolesc Gynecol. 2005
  3. 8 3. Duval B., Gilca V., McNeil S., Dobson S., Money D., Gemmill IM., Sauvageau C., Lavoie F., Ouakki M. Vaccination against human papillomavirus: a baseline survey of Canadian clinicians’ knowledge, attitudes and beliefs. Vaccine 2007
  4. 7 4. Schlecht NF., Kulaga S., Robitaille J., Ferreira S., Santos M., Miyamura RA., et al. Persistan human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA 2001
  5. 286(24):3106-14 5. Rouzier R., Uzan C., Collinet P. HPV vaccination: principles, results and future perspectives. J Gynecol Obstet Biol Reprod 2007
  6. 8 6. Clifford GM., Rana RK., Franceschi S., Smith JS., Gough G., Pimenta JM. Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by genographic region and with cervical cancer. Cancer Epidemiol Biomarkers Prev. 2005
  7. 64 7. Hampl M. Prevention of human papillomavirus-induced preneoplasia and cancer by prophylactic HPV vaccines. Minevra Med. 2007
  8. 30 8. Huh WK., Kendrick JE., Alvarez RD. New advances in vaccine technology and improved cervical cancer prevention. Obstet Gynecol 2007
  9. 92 9. WHO Human papillomavirus and related cancers in the world. Summary report. Burden of HPV related cancers. 2010:8-23 10. Arvaz M., Gezer A. Human papillomavirus vaccines. J Turkish-German Gynecol Assoc 2006
  10. 5 11. Turkish cervical cancer and cervical cytology research group prevalence of cervical cytological abnormalities in Turkey. Int J Gynaecol Obstet 2009
  11. 9 12. Wright TC Jr., Cox JT., Massad LS., Twiggs LB., Wilkinson EJ., ASCCP-Sponsored Consensus Conference. 2001 Consensus Guidelines fort he management of women with cervical cytological abnormalities. JAMA 2002
  12. 287(16):2120-9 13. Leddy MA., Anderson BL., Gall S., Schulkin J. Obstetrician-gynecologists and the HPV vaccine: practice patterns, beliefs, and knowledge. J Pediatr Adolesc Gynecol 2009
  13. 46 14. de Carvalho NS., Teixeira LM., Pradel EM., Gabardo J., Joly C., Urbanetz AA. Vaccinating against HPV: physicians’ and medical students’ point of view. Vaccine 2009
  14. 40 15. Koc F., Aksit S., Kurugol Z., Koturoglu G., Halıcıoglu O.